Literature DB >> 12897560

Temporal bone histopathological and quantitative analysis of mitochondrial DNA in MELAS.

Katsumasa Takahashi1, Saumil N Merchant, Tetsuo Miyazawa, Toshikazu Yamaguchi, Michael J McKenna, Hiroko Kouda, Yukiko Iino, Tsutomu Someya, Yuya Tamagawa, Yoshihisa Takiyama, Imaharu Nakano, Ken Saito, Philip Boyer, Ken Kitamura.   

Abstract

OBJECTIVES/HYPOTHESIS: Although hearing loss is common in MELAS (syndrome of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes), the histopathology of the temporal bone has not been reported. The majority of cases of MELAS are linked to a mitochondrial DNA (mtDNA) mutation at nucleotide 3243. In MELAS, normal mtDNA and mutant mtDNA coexist in a heteroplasmic manner. The purpose of the study was to report the otopathological findings from two patients with MELAS and quantitative mtDNA analysis in the inner ear of one of these patients. STUDY
DESIGN: Basic scientific histopathological examination and quantitative mtDNA analysis of the temporal bone.
METHODS: Temporal bones were embedded in celloidin and sectioned for light microscopic study. Graphic reconstruction of the cochlea was performed using the method described by Schuknecht. For quantitative mtDNA analysis, total DNA from the membranous part of the inner ear was collected, amplified by polymerase chain reaction, and digested with the restriction enzyme. The percentage of mutant/total mtDNA was measured by the ratio of fluorescence intensity.
RESULTS: Histopathological examination revealed severe degeneration of the stria vascularis and degenerative change of spiral ganglion cells in both patients. The quantitative DNA studies showed that the proportion of mutant to wild-type mtDNA was similar in both histologically affected and histologically unaffected tissues within the inner ear.
CONCLUSION: Dysfunction of the stria vascularis and spiral ganglion cells causes sensorineural hearing loss in MELAS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897560     DOI: 10.1097/00005537-200308000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Maternally inherited deafness and unusual phenotypic manifestations associated with A3243G mitochondrial DNA mutation.

Authors:  Katalin Komlósi; Richárd Kellermayer; Anita Maász; Viktória Havasi; Katalin Hollódy; Olga Vincze; Hajnalka Merkli; Endre Pál; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Systematic analysis of mitochondrial genes associated with hearing loss in the Japanese population: dHPLC reveals a new candidate mutation.

Authors:  Hideki Mutai; Hiroko Kouike; Eiko Teruya; Ikuko Takahashi-Kodomari; Hiroki Kakishima; Hidenobu Taiji; Shin-ichi Usami; Torayuki Okuyama; Tatsuo Matsunaga
Journal:  BMC Med Genet       Date:  2011-10-12       Impact factor: 2.103

3.  Sensorineural hearing loss in patients with chronic progressive external ophthalmoplegia or Kearns-Sayre syndrome.

Authors:  C Kornblum; R Broicher; E Walther; S Herberhold; T Klockgether; C Herberhold; R Schröder
Journal:  J Neurol       Date:  2005-04-15       Impact factor: 4.849

4.  Protective roles of alpha-lipoic acid in rat model of mitochondrial DNA4834bp deletion in inner ear.

Authors:  Wei Peng; Yujuan Hu; Yi Zhong; Bei Chen; Yu Sun; Yang Yang; Weijia Kong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

5.  Cochlear Implantation in Patients with Mitochondrial Gene Mutation: Decline in Speech Perception in Retrospective Long-Term Follow-Up Study.

Authors:  Kai Kanemoto; Akinori Kashio; Erika Ogata; Yusuke Akamatsu; Hajime Koyama; Tsukasa Uranaka; Yujiro Hoshi; Shinichi Iwasaki; Tatsuya Yamasoba
Journal:  Life (Basel)       Date:  2022-03-26

Review 6.  Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss.

Authors:  Teru Kamogashira; Chisato Fujimoto; Tatsuya Yamasoba
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

7.  Hearing impairment in MELAS: new prospective in clinical use of microRNA, a systematic review.

Authors:  Arianna Di Stadio; Valentina Pegoraro; Laura Giaretta; Laura Dipietro; Roberta Marozzo; Corrado Angelini
Journal:  Orphanet J Rare Dis       Date:  2018-02-21       Impact factor: 4.123

Review 8.  MicroRNAs are appropriate in mitochondrial related hearing loss? Answer to the skepticism.

Authors:  Arianna Di Stadio; Corrado Angelini
Journal:  Orphanet J Rare Dis       Date:  2018-07-18       Impact factor: 4.123

9.  Temporal bone histopathology in MELAS syndrome.

Authors:  Ophir Handzel; Omer J Ungar; Dan J Lee; Joseph B Nadol
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-07

10.  Long-Term Progression and Rapid Decline in Hearing Loss in Patients with a Point Mutation at Nucleotide 3243 of the Mitochondrial DNA.

Authors:  Aki Sakata; Akinori Kashio; Hajime Koyama; Tsukasa Uranaka; Shinichi Iwasaki; Chisato Fujimoto; Makoto Kinoshita; Tatsuya Yamasoba
Journal:  Life (Basel)       Date:  2022-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.